Treatments for alcohol use disorder (AUD) have been historically evaluated by consumption-based outcomes, such as the percentage of days abstinent from alcohol (PDA). There are many advantages of alcohol consumption as a primary outcome, given that it is easily quantified (e.g., via standard drinks) and because alcohol consumption is inherently associated with AUD. However, researchers, clients, and treatment providers have all agreed that the process of recovering from AUD involves more than consumption alone (e.g., Donovan et al., 2005; Kaskutas et al., 2014; Neale et al., 2015). Recent efforts have called for a shift away from defining consumption as the marker of AUD treatment success (Witkiewitz, 2013a), given that defining treatment success primarily by amount of consumption often fails to adequately portray the recovery process (e.g., Donovan et al., 2012; Substance Abuse and Mental Health Services Administration, 2012; Tiffany et al., 2012). Yet, efforts to move toward including non-consumption outcome measures have been stymied for two primary reasons. First, it is assumed that consumption measures are more sensitive and, therefore, consumption must be used as a surrogate measure for more clinically meaningful non- consumption measures (FDA, 2015, p. 2). Second, research is needed to direct researchers toward the best gold standard measures to use among AUD populations and studies of measurement invariance over time of these measures are largely non-existent.
The aims of the proposed study will address these two concerns via secondary data analysis of two of the largest AUD treatment research studies conducted in the United States: the COMBINE Study and Project MATCH (Anton et al., 2006; Project MATCH Research Group, 1997). The present study will examine the sensitivity and specificity (Aim 1), as well as the reliability, validity, and measurement invariance (Aim 2), of non-consumption measures available in the COMBINE study and Project MATCH. The non-consumption outcome variables to be examined are consistent with the variables identified as important to researchers, clients and their loved ones, and treatment providers: 1) alcohol-related problems, 2) mental health, 3) craving/temptation, 4) psychosocial functioning/quality of life, 5) physical health, 6) financial status, and 7) self-efficacy. Sensitivity and specificity will be evaluated using Receiver Operatin Characteristic (ROC) curve analyses (Hanley & McNeil, 1982) predicting outcome data from immediately post- and 12-month post-treatment for: 1) abstinence, 2) no heavy drinking days (Falk et al., 2010), 3) the World Health Organization risky drinking levels (European Medicines Agency, 2010), and 4) a composite clinical outcome defined by consumption and alcohol-related problems (Cisler & Zweben, 1999). Reliability, validity, and measurement invariance will be assessed using latent variable modeling approaches. The two aims of this study will address longstanding and untested assumptions that have prevented researchers from shifting toward more clinically meaningful definitions of treatment success that include non-consumption outcomes.

Public Health Relevance

Abstinence from alcohol has historically been considered the primary indicator of treatment success for alcohol use disorder (AUD) treatment. Abstinence from alcohol may indicate a successful outcome; however, there is growing recognition that AUD recovery is more complex than achieving abstinence and defining treatment success primarily by consumption alone often fails to adequately portray the recovery process. Efforts to move toward non-consumption, clinically meaningful outcome measures (e.g., reduced alcohol-related problems) have been largely limited by the untested assumption that consumption measures are more sensitive than non- consumption measures and by the lack of research identifying 'gold standard' non-consumption measures. The proposed study aims to address these limitations through empirical analyses of existing non-consumption outcome measures in order to identify those measures that could be considered 'gold standard' measures of non-consumption outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31AA024959-02
Application #
9352672
Study Section
National Institute on Alcohol Abuse and Alcoholism Initial Review Group (AA)
Program Officer
Hagman, Brett Thomas
Project Start
2016-04-11
Project End
2017-08-06
Budget Start
2017-04-11
Budget End
2017-08-06
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Type
Organized Research Units
DUNS #
868853094
City
Albuquerque
State
NM
Country
United States
Zip Code
87106
Kirouac, Megan; Witkiewitz, Katie (2018) Revisiting the Drinker Inventory of Consequences: An extensive evaluation of psychometric properties in two alcohol clinical trials. Psychol Addict Behav 32:52-63
Witkiewitz, Katie; Roos, Corey R; Pearson, Matthew R et al. (2017) How Much Is Too Much? Patterns of Drinking During Alcohol Treatment and Associations With Post-Treatment Outcomes Across Three Alcohol Clinical Trials. J Stud Alcohol Drugs 78:59-69
Kirouac, Megan; Witkiewitz, Katie (2017) Identifying ""Hitting Bottom"" Among Individuals with Alcohol Problems: Development and Evaluation of the Noteworthy Aspects of Drinking Important to Recovery (NADIR). Subst Use Misuse 52:1602-1615
Witkiewitz, Katie; Pearson, Matthew R; Hallgren, Kevin A et al. (2017) Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials. Addiction 112:2112-2121
Pearson, Matthew R; Bravo, Adrian J; Kirouac, Megan et al. (2017) The search for an elusive cutoff remains: Problems of binary classification of heavy drinking as an endpoint for alcohol clinical trials. Drug Alcohol Depend 171:91-96
Kirouac, Megan; Stein, Elizabeth R; Pearson, Matthew R et al. (2017) Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder. Qual Life Res 26:2987-2997
Kirouac, Megan; Witkiewitz, Katie; Donovan, Dennis M (2016) Client Evaluation of Treatment for Alcohol Use Disorder in COMBINE. J Subst Abuse Treat 67:38-43
Pearson, Matthew R; Kirouac, Megan; Witkiewitz, Katie (2016) We still question the utility and validity of the binge/heavy drinking criterion. Addiction 111:1733-4